Table 3.
Clinical outcome
| CONTROL | PRESSURE | GDFT | P-value | |
|---|---|---|---|---|
| (N = 40) | (N = 40) | (N = 40) | ||
| Rate of complications (all) | 33 (83 %) | 26 (65 %) | 22 (55 %)a | 0.03 |
| Rate of complications (major) | 3 (8 %) | 6 (15 %) | 2 (5 %) | 0.27 |
| Mortality | 0 (0 %) | 1 (2.5 %) | 0 (0 %) | 0.37 |
| Hospital length of stay (days) | 10.5 (8–12) | 10 (9–12.5) | 10 (8.5–13.5) | 0.99 |
| Discharge readiness (days) | 9 (8–12) | 9 (7–12) | 8 (7–10) | 0.06 |
| ICU length of stay (days) | 2 (2–2) | 2 (2–3) | 2 (2–3) | 0.3 |
| ICU readiness (days) | 2 (2–2) | 2 (2–2) | 2 (2–2) | 0.38 |
| Number of complications (all) | 66 | 61 | 35 | N/A |
| Number of complications (major) | 3 | 8 | 3 | N/A |
| Blood transfusion (patients) | 30 (75 %) | 25 (63 %) | 15 (38 %)a | 0.001 |
| Blood transfusion (units) | 2 (1–4) | 2 (0–4) | 0 (0–2) | N/A |
| Complications per group (Number of patients) | ||||
| Cardiovascular | ||||
| Minor | 2 (5 %) | 4 (10 %) | 0 (0 %) | 0.12 |
| Major | 0 (0 %) | 1 (2.5 %) | 1 (2.5 %) | 0.6 |
| Respiratory | ||||
| Minor | 1 (2.5 %) | 1 (2.5 %) | 0 (0 %) | 0.6 |
| Major | 0 (0 %) | 1 (2.5 %) | 0 (0 %) | 0.37 |
| Infectious | ||||
| Minor | 23 (57.5 %) | 9 (22.5 %)a | 9 (22.5 %)a | 0.001 |
| Major | 2 (5 %) | 3 (7.5 %) | 2 (5 %) | 0.86 |
| Renal | ||||
| Minor | 5 (12.5 %) | 7 (17.5 %) | 5 (12.5 %) | 0.76 |
| Major | 0 (0 %) | 0 (0 %) | 0 (0 %) | 1 |
| GIT | ||||
| Minor | 20 (50 %) | 17 (42.5 %) | 11 (27.5 %) | 0.12 |
| Major | 0 (0 %) | 0 (0 %) | 0 (0 %) | 1 |
| Nervous | ||||
| Minor | 1 (2.5 %) | 3 (7.5 %) | 3 (7.5 %) | 0.55 |
| Major | 0 (0 %) | 0 (0 %) | 0 (0 %) | 1 |
| Coagulation | ||||
| Minor | 6 (15 %) | 7 (17.5 %) | 3 (7.5 %) | 0.39 |
| Major | 1 (2.5 %) | 2 (5 %) | 0 (0 %) | 0.36 |
Data are presented as median (interquartil range) or number (proportion)
ICU intensive care unit, GIT gastro-intestinal tract
a - significant difference between protocolled group (GDFT or PRESSURE) vs. CONTROL